Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aileron Therapeutics Inc (ALRN)
NASDAQ:ALRN
Aileron Therapeutics (ALRN) Stock Price & Analysis
1,176 Followers
ALRN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.01 - $7.42
Previous Close$3.69
Volume29.50K
Average Volume (3M)92.19K
Market Cap
$79.67M
Enterprise Value$67.62M
Total Cash (Recent Filing)$12.04M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.2
Beta1.20
Next Earnings
Aug 07, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.19
Shares Outstanding21,589,576
10 Day Avg. Volume66,357
30 Day Avg. Volume92,189
Standard Deviation0.38
R-Squared0.10
Alpha-0.00568
Financial Highlights & Ratios
Price to Book (P/B)-2.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.80
Forecast
1Y Price Target
$19.00Price Target Upside414.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aileron Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALRN FAQ
What was Aileron Therapeutics Inc’s price range in the past 12 months?
Aileron Therapeutics Inc lowest stock price was $1.01 and its highest was $7.42 in the past 12 months.
What is Aileron Therapeutics Inc’s market cap?
Currently, no data Available
When is Aileron Therapeutics Inc’s upcoming earnings report date?
Aileron Therapeutics Inc’s upcoming earnings report date is Aug 07, 2024 which is in 78 days.
How were Aileron Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Aileron Therapeutics Inc overvalued?
According to Wall Street analysts Aileron Therapeutics Inc’s price is currently Undervalued.
Does Aileron Therapeutics Inc pay dividends?
Aileron Therapeutics Inc does not currently pay dividends.
What is Aileron Therapeutics Inc’s EPS estimate?
Aileron Therapeutics Inc’s EPS estimate is -$0.16.
How many shares outstanding does Aileron Therapeutics Inc have?
Aileron Therapeutics Inc has 21,589,577 shares outstanding.
What happened to Aileron Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aileron Therapeutics Inc?
Currently, no hedge funds are holding shares in ALRN
---
Aileron Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$19.00 (414.91% Upside)
$19.00 (414.91% Upside)
Insider Transactions
Sold Shares
Worth $139.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
171.32%
12-Months-Change
Fundamentals
Return on Equity
-34.21%
Trailing 12-Months
Asset Growth
478.14%
Trailing 12-Months
Company Description
Aileron Therapeutics Inc
Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead products candidate, ALRN-6924 which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky in June 2005 and is headquartered in Cambridge, MA.
---
ALRN Stock 12 Month Forecast
Average Price Target
$19.00
▲(414.91% Upside)
Technical Analysis
Adverum Biotechnologies
―
Arvinas Holding Company
―
Crinetics Pharmaceuticals
―
Kura Oncology
―
Best Analysts Covering ALRN
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-17.17%
reiterated a buy rating last month
Copying Aydin Huseynov's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -17.17% per trade.
---